QURE

uniQure is a Netherlands-based gene therapy biotechnology company focused on developing treatments for patients with severe genetic diseases. The company has a leading hemophilia B gene therapy candidate and a pipeline targeting other rare disorders. uniQure combines proprietary adeno-associated virus (AAV) technology with clinical development expertise to advance potentially curative one-time treatments.